Sauliaus Vaitkaus ausų nosies gerklės ligų klinika, MB - financials and debts

Company age: 9 y. 4 mo.

Update

Sauliaus Vaitkaus ausų nosies gerklės ligų klinika - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 9,815 13,699 16,368 23,669 47,164 43,965 35,894
Profit before tax - 62 -330 5,963 5,214 7,485 8,372 -3,695
Net profit 0 62 -330 5,963 5,214 7,485 7,953 -3,695
Equity - 133 -397 5,566 10,780 7,488 7,953 -3,695
Liabilities 0 - - 6,499 6,496 9,783 6,379 14,331
Non-current assets 0 0 0 0 0 0 0 0
Current assets 0 433 6,103 12,065 17,276 17,271 14,332 10,636
Total assets 0 433 6,103 12,065 17,276 17,271 14,332 10,636
Taxes paid
STI taxes - - - - - 1,015 3,379 7,005
Social insurance contributions - - - - - - - 799
Financial indicators
Revenue change y/y - - +39.6% +19.5% +44.6% +99.3% -6.8% -18.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - 14.3% -5.4% 49.4% 30.2% 43.3% 55.5% -34.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 46.6% - 107.1% 48.4% 100.0% 100.0% -
Profit margin Net profit margin. Shows the overall profitability of the company. - 0.6% -2.4% 36.4% 22.0% 15.9% 18.1% -10.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 0.6% -2.4% 36.4% 22.0% 15.9% 19.0% -10.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 1.2 0.6 1.3 0.8 -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 4,908 5,871 5,456 7,890 15,721 14,655 9,789

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sauliaus Vaitkaus ausų nosies gerklės ligų klinika - Social security debts

The amount of overdue SODRA debt for the company Sauliaus Vaitkaus ausų nosies gerklės ligų klinika as of the last working day is: 28 €

From To Debt, €
2026-09-05 2026-09-14 28.11
2026-08-26 2026-09-02 28.11
2026-08-23 2026-08-23 28.11
2026-08-19 2026-08-19 28.11
2026-08-16 2026-08-17 0.72
2026-08-14 2026-08-14 0.72
2026-05-17 2026-05-21 52.51
2026-05-03 2026-05-14 25.99
2026-04-24 2026-04-29 0.31
2026-03-27 2026-03-27 55.66
2026-03-17 2026-03-24 55.66
2026-03-15 2026-03-16 28.30
2026-02-18 2026-03-11 28.30
2026-01-21 2026-02-17 0.94
2025-12-16 2025-12-18 123.95
2025-11-18 2025-12-15 74.63
2025-10-27 2025-11-17 37.64
2025-10-26 2025-10-26 36.99
2025-10-23 2025-10-25 37.64
2025-10-16 2025-10-22 36.99
2025-09-16 2025-09-24 99.66
2025-09-07 2025-09-15 50.34
2025-08-31 2025-09-03 50.34
2025-08-19 2025-08-29 50.34
2025-07-24 2025-08-18 1.02
2025-06-17 2025-07-15 80.24
2025-06-11 2025-06-16 37.09
2025-06-08 2025-06-09 37.09
2025-05-16 2025-06-04 37.09
2025-05-04 2025-05-15 0.10
2025-04-24 2025-04-29 0.10
2025-04-16 2025-04-21 36.99
2025-03-18 2025-03-27 21.78
2025-02-18 2025-03-17 3.30
2025-01-16 2025-01-20 14.22
2024-12-22 2024-12-29 49.67
2024-12-17 2024-12-20 49.67
2024-11-18 2024-12-16 33.20
2024-10-29 2024-11-17 16.73
2024-10-28 2024-10-28 16.47
2024-10-24 2024-10-27 16.73
2024-10-16 2024-10-23 16.47
2024-09-17 2024-09-25 35.82
2024-08-19 2024-09-16 19.35
2024-07-24 2024-08-18 2.88
2024-07-16 2024-07-23 2.78
2024-04-23 2024-05-13 13.37
2024-04-16 2024-04-22 12.34
2024-03-18 2024-03-20 75.87
2024-02-19 2024-03-17 59.40
2024-01-23 2024-02-18 42.93
2024-01-16 2024-01-22 42.26
2023-12-18 2024-01-11 42.26
2023-11-20 2023-12-17 26.54
2023-10-17 2023-11-19 10.82
2023-05-16 2023-06-15 31.79
2023-05-02 2023-05-15 16.07
2023-04-25 2023-04-28 16.07
2023-04-18 2023-04-24 15.72
2023-03-16 2023-03-22 31.75
2023-02-17 2023-03-15 16.03
2023-02-06 2023-02-16 0.31
2023-01-26 2023-02-03 0.31
2023-01-23 2023-01-25 47.14
2023-01-17 2023-01-22 46.83
2022-12-16 2022-12-29 30.83
2022-11-21 2022-12-15 15.74
2022-11-17 2022-11-18 15.74
2022-10-18 2022-10-24 15.09
2022-09-16 2022-09-22 15.09
2022-08-23 2022-08-29 30.18
2022-07-18 2022-08-22 15.09
2022-06-16 2022-06-27 15.09
2022-05-18 2022-05-23 15.09
2022-05-17 2022-05-17 28.89
2022-04-19 2022-05-16 13.80
2022-03-16 2022-03-20 15.09
2022-02-28 2022-03-02 15.17
2022-02-17 2022-02-27 0.14
2021-12-16 2021-12-20 15.03
2021-11-16 2021-11-18 15.12
2021-11-09 2021-11-15 0.09
2021-10-18 2021-10-21 12.45
2021-09-16 2021-09-26 10.05

Sauliaus Vaitkaus ausų nosies gerklės ligų klinika - VMI tax arrears

From To Overdue, €
2026-04-01 2026-05-20 3.1
2026-03-27 2026-03-31 2.95
2026-03-20 2026-03-26 5.9
2026-03-08 2026-03-19 2.95
2026-03-02 2026-03-07 915.78
2026-02-14 2026-03-01 912.83
2025-07-10 2026-01-30 1.76
2025-07-03 2025-07-09 1.54
2025-07-01 2025-07-02 433.35
2025-06-19 2025-06-30 431.81
2025-01-22 2025-06-18 12.81

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sauliaus Vaitkaus ausu nosies gerkles ligu klinika, MB (code 304535957) is a Lithuanian small partnership engaged in medical specialists activities. In the latest financial year, 2025, revenue amounted to €35.9K and the company posted a net loss of €3.7K, corresponding to a profit margin of -10.3%. Performance weakened compared with 2024, when revenue was €44.0K and net profit was €8.0K, and also versus 2023, when revenue reached €47.2K and net profit was €7.5K. Over the two-year period, revenue declined by 23.9%, showing a clear downward trend. The balance sheet also softened: total assets fell to €10.6K in 2025 from €14.3K in 2024, while liabilities increased to €14.3K and equity turned negative at -€3.7K. Asset turnover remained high at 3.37x, indicating active use of the asset base. Revenue per employee was €12.0K, and profit per employee was -€1.2K, reflecting the weaker operating result in 2025.